Press Release: Wexford Capital : AZTherapies Closes $26.3 Million Series C Preferred Equity Financing
BOSTON, Oct. 17, 2019 (GLOBE NEWSWIRE) -- AZTherapies, Inc. , a biopharmaceutical company developing therapeutics to extend brain health, today announced the...
Read full article »
Wexford Capital is an employee owned hedge fund sponsor.
Read more